Ashg Capital Inc

Aerotest Operations, Inc. is a specialized provider of neutron radiography services, offering high-quality imaging solutions with a film size of 14x17 inches and the capability to mount parts horizontally. The company features five different resolution settings to ensure sharp images and maintains high contrast and uniform density across the entire film area. With a focus on training, Aerotest Operations also offers classes in neutron radiography for N-ray interpreters, alongside a free demonstration service for new applications to assess feasibility. The experienced staff at Aerotest comprises professionals with over 25 years of expertise in the design and development of nuclear devices, including activation analyses, irradiations, and radiation damage studies. Generated from the website

Talentmine LLC, located in San Ramon, CA, specializes in providing staffing and consulting services within the life sciences sector, offering solutions that encompass both permanent and temporary placements. With a focus on various functions such as biostatistics, clinical programming, and regulatory affairs, Talentmine is dedicated to connecting clients with the right talent to drive success in their organizations. As a leading global recruiting partner, Talentmine has integrated with Orbis Clinical, enhancing its capabilities and resources to deliver superior staffing solutions. This partnership allows Talentmine to serve a broad range of clients, from venture-backed startups to Fortune 500 companies, while expanding job opportunities for its consultants in the biotechnology, pharmaceutical, and medical device industries. Generated from the website

BioMetis Technology Inc., located in Hayward, California, is a pioneer in AI-powered biotechnology, specializing in AIDME (AI-Directed Molecular Evolution) technology that promotes innovation in synthetic biology. The company focuses on integrated solutions for protein design and genome engineering, catering to various industrial applications, particularly in environmental protection and therapeutics. Established in 2020, BioMetis has made significant advancements in protein engineering and plastic degradation, supported by a growing patent portfolio that underscores its global leadership in the field. Their cutting-edge technology not only addresses pressing challenges in multiple sectors but also emphasizes the creation of sustainable, high-performance enzyme solutions. Generated from the website